FDA Approves GLP-1 Drugs for Fatty Liver Disease With 63% Success Rate
New clinical trials show GLP-1 medications like Ozempic can reverse fatty liver disease in up to 62% of patients within 72 weeks.
20 articles
New clinical trials show GLP-1 medications like Ozempic can reverse fatty liver disease in up to 62% of patients within 72 weeks.
New research reveals how fecal transplants from 100-year-olds may slow aging, while your own microbiome can help maintain weight loss.
Major cardiovascular trial shows PCSK9 inhibitors prevent first heart attacks and strokes, plus new oral formulation makes treatment more accessible.
First new COPD medication in over a decade targets dual pathways to improve breathing and reduce inflammation.
Research reveals how this ancient spice's unique amino acid helps regulate insulin naturally without dangerous blood sugar crashes.
Retatrutide shows unprecedented weight loss results in phase 3 trials, but higher side effects may limit its advantage over existing medications.
Thomas DeLauer reveals how glycine supports liver detoxification, boosts glutathione production, and enhances metabolic flexibility.
Plant-based Portfolio Diet achieves drug-like 30% LDL reduction through four specific food categories without pharmaceutical side effects.
Dr. Fung breaks down four distinct fasting approaches, including a surprising fourth type that involves consuming calories during extended fasts.
Siim Land breaks down the exact steps to dramatically reduce visceral fat based on your starting point and current research.
New FDA-approved medication Ensifentrine offers hope for COPD patients by targeting airway inflammation and improving breathing function.
How 2g of L-serine amino acid strengthens gut mucus barrier and stops neuroinflammation causing brain fog.
Deep dive into epitalon's longevity claims reveals impressive animal studies but questionable human research from controversial Russian scientist.
Thomas DeLauer explains how psyllium husk forms a gel barrier in your gut to physically slow glucose absorption and improve insulin sensitivity.
Dr. Stanfield reveals why longevity investments crash and burn, plus four medication classes showing real promise for healthspan extension.
Glycine supplementation may slow aging by reducing AGEs, harmful molecules that damage collagen and drive chronic disease.
Recent meta-analysis reveals spirulina's modest effects on weight, cholesterol, and blood pressure in overweight individuals.
Brian Johnson's tirzepatide experiment sparked interest in microdosing GLP-1s for anti-aging, but evidence remains hypothetical with real risks.
Personal experiment with glycine and NAC reveals improved workout recovery and reduced muscle soreness based on clinical research.
Thomas DeLauer explains why L-serine may be more effective than vitamin C, NAC, and turmeric by boosting your body's natural antioxidant systems.